And what they found was that people who lived to 90 or 100 were more likely to have daf-2 mutations -- that is, changes in the gene that encodes the receptor for IGF-1.
O que descubriron foi que era mais probable que as persoas que viviran ata os 90 ou 100 tiveran mutación daf-2, é dicir, cambios no xen que codifica o receptor de IGF-1.